滚动资讯
FierceBiotechMadrigal continues MASH deal spree with $1B biobucks license for Arrowhead asset rejected by J&JEndpoints NewsSwiss manufacturing, biotech industry so far unfazed by geopoliticsEndpoints NewsPfizer ends Trillium-related development as R&D spend jumpsEndpoints NewsMicrobiome startup raises $48M for immunotherapy and malnutrition treatmentsEndpoints News强生IBD组合疗法二期研究未达预期,但仍将推进关键性试验FierceBiotech辉瑞23亿美元收购Trillium的赌注以失败告终,剩余CD47阻断剂与T细胞接合器一并被放弃FierceBiotech赛诺菲扩大AI能力,投资2.94亿美元扩建多伦多中心Endpoints NewsMadrigal延续MASH交易连胜,签约强生放弃的Arrowhead药物Endpoints News医疗组织正日益构建自己的AI工具PharmaVoice安进公司与FDA对决的关键所在Promega Blog超越肝脏:脂质纳米颗粒如何拓展mRNA递送的应用范围BioPharma DiveVertex的盈利报告引发投资者反应平淡

资讯库

总数 10140
页码 526 / 564
搜索 --